This independent UPLC-MS lab test confirms Tirzepatide 14.8mg from Direct Peptides at 99.45% purity. The analysis was conducted by Horizon Analytical on March 11, 2026. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.45% indicates minimal contamination and high-grade synthesis. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.